§ 11.100 General requirements.
(a) Each electronic signature shall be unique to one individual and shall not be reused by, or reassigned to, anyone else.
(b) Before an organization establishes, assigns, certifies, or otherwise sanctions an individual's electronic signature, or any element of such electronic signature, the organization shall verify the identity of the individual.
(c) Persons using electronic signatures shall, prior to or at the time of such use, certify to the agency that the electronic signatures in their system, used on or after August 20, 1997, are intended to be the legally binding equivalent of traditional handwritten signatures.
(1) The certification shall be signed with a traditional handwritten signature and submitted in electronic or paper form. Information on where to submit the certification can be found on FDA's web page on Letters of Non-Repudiation Agreement.
(2) Persons using electronic signatures shall, upon agency request, provide additional certification or testimony that a specific electronic signature is the legally binding equivalent of the signer's handwritten signature.
[62 FR 13464, Mar. 20, 1997, as amended at 88 FR 13018, Mar. 2, 2023]
How BatchGlow handles this
Each user signs with a personal PIN that only they set, and a signing token is issued to that user alone and checked against them when it is used; the shared Administrator account cannot sign a product bill of materials.
What it asks for, in plain words
- 21 CFR 11.100
- Each electronic signature belongs to one individual and is never reused by or reassigned to anyone else. The organization verifies the individual's identity before it establishes or certifies the signature, and certifies to the FDA, in a letter signed by hand, that the electronic signatures in its system are intended to be the legally binding equivalent of handwritten signatures.
These summaries are BatchGlow's reading of the text on this page, checked against it on 5 Oct 2026. The text governs.